This topic contains a solution. Click here to go to the answer

Author Question: Which of the following cardiac cells has the slowest action potential? a. Atrial c. Purkinje ... (Read 67 times)

Jramos095

  • Hero Member
  • *****
  • Posts: 528
Which of the following cardiac cells has the slowest action potential?
 
  a. Atrial c. Purkinje fiber
  b. Ventricular d. Sinoatrial node

Question 2

Electrical stimulation of a cardiac muscle cell is the definition of which of the following?
 
  a. Contraction c. Polarization
  b. Refraction d. Depolarization



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

daiying98

  • Sr. Member
  • ****
  • Posts: 354
Answer to Question 1

ANS: D
The slope of phase 0 of the sinoatrial node (pacemaker) is less than those of the atrial, ventricular, and Purkinje fiber action potentials, and the former often is referred to as a slow action potential, whereas the latter are called fast action potentials.

Answer to Question 2

ANS: D
The action potential begins when the cell membrane of the excitable cell is exposed to a depolar-izing current and eventually reaches its excitation threshold potential. This is known as depolari-zation.




Jramos095

  • Member
  • Posts: 528
Reply 2 on: Jul 16, 2018
:D TYSM


TheDev123

  • Member
  • Posts: 332
Reply 3 on: Yesterday
Excellent

 

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

Methicillin-resistant Staphylococcus aureus or MRSA was discovered in 1961 in the United Kingdom. It if often referred to as a superbug. MRSA infections cause more deaths in the United States every year than AIDS.

Methicilli ...
Did you know?

For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library